Clinical Imaging
Volume 31, Issue 4 , Pages 253-258, July 2007

Benefit of CT venography for the diagnosis of thromboembolic disease

  • Kyung Hwa Rhee

      Affiliations

    • Department of Radiology, NYU Medical Center New York, NY 10016, USA
  • ,
  • Ramesh S. Iyer

      Affiliations

    • Department of Radiology, NYU Medical Center New York, NY 10016, USA
  • ,
  • Susan Cha

      Affiliations

    • Department of Radiology, NYU Medical Center New York, NY 10016, USA
  • ,
  • David P. Naidich

      Affiliations

    • Department of Radiology, NYU Medical Center New York, NY 10016, USA
  • ,
  • Henry Rusinek

      Affiliations

    • Department of Radiology, NYU Medical Center New York, NY 10016, USA
  • ,
  • Glenn R. Jacobowitz

      Affiliations

    • Division of Vascular Surgery, Department of Surgery, NYU Medical Center New York, NY 10016, USA
  • ,
  • Jane P. Ko

      Affiliations

    • Department of Radiology, NYU Medical Center New York, NY 10016, USA
    • Corresponding Author InformationCorresponding author. Thoracic Imaging, Department of Radiology, NYU Medical Center, 560 1st Avenue, New York, NY 10016, USA. Tel.: +1 212 263 5229; fax: +1 212 263 7348.

Received 10 November 2006; accepted 15 February 2007. published online 10 May 2007.

Abstract 

Objective

The aim of this study was to determine the benefit of lower extremity CT venography (CTV) with pulmonary CT angiography (CTA) for diagnosing thromboembolic (TE) disease.

Subjects and Methods

Reports of all CTAs and CTVs over a 3-year interval (Group I) and CTAs, CTVs, and lower extremity Doppler ultrasounds (US) over a 1 1/2-year subset (Group II) were reviewed. Patient population was inpatients and emergency department patients who were assessed for pulmonary embolism (PE) and deep venous thrombosis (DVT) at a tertiary care hospital. Reported results for CTA or CTV were categorized as positive (CTAP, CTVP), negative (CTAN, CTVN), or indeterminate for PE or DVT. When CTV and US results were discrepant, medical records were reviewed for clinical management. Additional benefit of CTV was assessed by chi-square analysis.

Results

In Group I, 737 (81.1%) of 909 CTAs from combined CTA/CTV studies were negative. The diagnosis rate of TE disease increased from 13.0% to 17.3% with the addition of CTVPs (P=.01). Of the 119 cases in Group II undergoing combined CTA, CTV, and US, CTV and US were both positive in eight and both negative in 88. Of the seven discordant CTVs and USs with clinical follow-up, five CTVs were positive while USs were negative, three of which were treated clinically for TE disease, while two were considered falsely positive. As CTA also proved positive in one of the three, CTV therefore affected management in two of these five cases and increased the rate of thromboembolism diagnosis from 21.0% to 22.6%; however, this was not significant (P>.05). Two CTVNs were managed as false negatives.

Conclusions

The combined use of CTA and CTV significantly increases the rate of TE disease over CTA alone. In cases in which ultrasound is performed, however, there is no significant advantage to performing combined CTA/CTV studies.

Keywords: Computed tomography, Pulmonary embolism, Venography, Angiography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0899-7071(07)00064-2

doi:10.1016/j.clinimag.2007.02.027

Clinical Imaging
Volume 31, Issue 4 , Pages 253-258, July 2007